This report contains market size and forecasts of Nuclear Receptor ROR Gamma in global, including the following market information: Global Nuclear Receptor ROR Gamma Market Revenue, 2017-2022, 2023-2028, ($ millions) Global Nuclear Receptor ROR Gamma Market Sales, 2017-2022, 2023-2028, (K Pcs) Global top five Nuclear Receptor ROR Gamma companies in 2021 (%) The global Nuclear Receptor ROR Gamma market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period. The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028. BBI-6000 Segment to Reach $ Million by 2028, with a % CAGR in next six years. The global key manufacturers of Nuclear Receptor ROR Gamma include Genfit SA, GlaxoSmithKline Plc, Aurigene Discovery Technologies, Beijing Hanmi Pharmaceutical, Biogen Inc, AbbVie Inc, Eurofins Advinus, Brickell Biotech Inc and Pfizer Inc, etc. In 2021, the global top five players have a share approximately % in terms of revenue. MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Nuclear Receptor ROR Gamma manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks. Total Market by Segment: Global Nuclear Receptor ROR Gamma Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs) Global Nuclear Receptor ROR Gamma Market Segment Percentages, by Type, 2021 (%) BBI-6000 GRC-39815Action R&D Progress GSK-2981278 IMU-366 INV-17 Others Global Nuclear Receptor ROR Gamma Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs) Global Nuclear Receptor ROR Gamma Market Segment Percentages, by Application, 2021 (%) Chronic Obstructive Pulmonary Disease Asthma Axial Spondyloarthritis Breast Cancer Others Global Nuclear Receptor ROR Gamma Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs) Global Nuclear Receptor ROR Gamma Market Segment Percentages, By Region and Country, 2021 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Competitor Analysis The report also provides analysis of leading market participants including: Key companies Nuclear Receptor ROR Gamma revenues in global market, 2017-2022 (Estimated), ($ millions) Key companies Nuclear Receptor ROR Gamma revenues share in global market, 2021 (%) Key companies Nuclear Receptor ROR Gamma sales in global market, 2017-2022 (Estimated), (K Pcs) Key companies Nuclear Receptor ROR Gamma sales share in global market, 2021 (%) Further, the report presents profiles of competitors in the market, key players include: Genfit SA GlaxoSmithKline Plc Aurigene Discovery Technologies Beijing Hanmi Pharmaceutical Biogen Inc AbbVie Inc Eurofins Advinus Brickell Biotech Inc Pfizer Inc Phenex Pharmaceuticals AG Reata Pharmaceuticals Inc Bristol-Myers Squibb Company Celgene Corp Eli Lilly Glenmark Pharmaceuticals Lead Pharma Holding BV
1 Introduction to Research & Analysis Reports 1.1 Nuclear Receptor ROR Gamma Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global Nuclear Receptor ROR Gamma Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Research Process
